Guardian Pharmacy Services, Inc.
GRDN
$20.09
$0.763.93%
| Weiss Ratings | GRDN - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D+ | |||
| Reward Grade | D+ | |||
| Rating Factors | GRDN - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Fair | |||
| Solvency Index | Good | |||
| Total Return Index | Weak | |||
| Volatility Index | Good | |||
| Beta / Standard Deviation | GRDN - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -- | |||
| Price History | GRDN - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 9.66% | |||
| 30-Day Total Return | -11.92% | |||
| 60-Day Total Return | -9.91% | |||
| 90-Day Total Return | 9.96% | |||
| Year to Date Total Return | 1.01% | |||
| 1-Year Total Return | -- | |||
| 2-Year Total Return | -- | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -21.94% | |||
| 52-Week Low % Change | 41.88% | |||
| Price | GRDN - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $25.74 | |||
| 52-Week Low Price | $14.16 | |||
| 52-Week Low Price (Date) | Sep 26, 2024 | |||
| 52-Week High Price (Date) | Dec 12, 2024 | |||
| Valuation | GRDN - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 1.27B | |||
| Enterprise Value | 1.32B | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -2.11 | |||
| Earnings Per Share Growth | -- | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 1.38 | |||
| Price/Book (Q) | 9.97 | |||
| Enterprise Value/Revenue (TTM) | 1.48 | |||
| Price | $20.09 | |||
| Enterprise Value/EBITDA (TTM) | -20.22 | |||
| Enterprise Value/EBIT | -16.51 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | GRDN - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 61.14M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | GRDN - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 404 810 0089 | |||
| Address | 300 Galleria Parkway SE Atlanta, GA 30339 | |||
| Website | guardianpharmacy.com | |||
| Country | United States | |||
| Year Founded | 2003 | |||
| Profitability | GRDN - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | GRDN - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -- | |||
| Return on Equity | -- | |||
| Income Statement | GRDN - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | $14.55 | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -- | |||
| EBIT (TTM) | -- | |||
| Net Income (TTM) | -- | |||
| Net Income Avl. to Common (TTM) | -- | |||
| Total Revenue Growth (Q YOY) | 19.66% | |||
| Earnings Growth (Q YOY) | -1,412.75% | |||
| EPS Diluted (TTM) | -- | |||
| EPS Diluted Growth (Q YOY) | -- | |||
| Balance Sheet | GRDN - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 37.22M | |||
| Cash Per Share (Q) | $0.61 | |||
| Total Current Assets (Q) | 180.27M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 133.90M | |||
| Current Ratio (Q) | 1.139 | |||
| Book Value Per Share (Q) | $2.02 | |||
| Total Assets (Q) | 348.03M | |||
| Total Current Liabilities (Q) | 158.32M | |||
| Total Debt (Q) | 74.90M | |||
| Total Liabilities (Q) | 214.13M | |||
| Total Common Equity (Q) | 127.57M | |||
| Cash Flow | GRDN - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | -- | |||
| Net Change in Cash (TTM) | -- | |||
| Levered Free Cash Flow (TTM) | -- | |||
| Cash from Operations (TTM) | -- | |||
